U.S. fraud charges pummel Indivior shares

U.S. fraud charges pummel Indivior shares

Source: 
BioCentury
snippet: 

Indivior fell 75.90p (72%) to 30.05p on Wednesday after the U.S. Department of Justice indicted the company for allegedly defrauding providers and payers to increase prescriptions of its opioid dependence drug Suboxone sublingual film. Wednesday's move translates to a market cap loss of £551.9 million ($721.9 million).